These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17327688)
1. Distinct pattern of allelic loss and inactivation of cadherin 1 and 5 genes in mammary carcinomas arising in p53(+/-) mice. Umesako S; Iiga S; Takahashi M; Imura K; Mori N; Hong DP; Song CW; Niwa O; Okumoto M J Radiat Res; 2007 Mar; 48(2):143-52. PubMed ID: 17327688 [TBL] [Abstract][Full Text] [Related]
2. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice. Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165 [TBL] [Abstract][Full Text] [Related]
3. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice. Cool M; Jolicoeur P Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Ritland SR; Rowse GJ; Chang Y; Gendler SJ Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830 [TBL] [Abstract][Full Text] [Related]
7. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Hulla JE; French JE; Dunnick JK Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746 [TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Haag JD; Hsu LC; Newton MA; Gould MN Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073 [TBL] [Abstract][Full Text] [Related]
9. Putative tumor suppressor gene region within 0.85 cM on chromosome 12 in radiation-induced murine lymphomas. Okumoto M; Song CW; Tabata K; Ishibashi M; Mori N; Park YG; Kominami R; Matsumoto Y; Takamori Y; Esaki K Mol Carcinog; 1998 Jul; 22(3):175-81. PubMed ID: 9688143 [TBL] [Abstract][Full Text] [Related]
10. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23. Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353 [TBL] [Abstract][Full Text] [Related]
11. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896 [TBL] [Abstract][Full Text] [Related]
12. Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci. Cool M; Depault F; Jolicoeur P Genes Chromosomes Cancer; 2006 Feb; 45(2):191-202. PubMed ID: 16258954 [TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
14. Allelic losses in mouse skin tumors induced by gamma-irradiation of p53 heterozygotes. Miyazawa T; Sato H; Hatakeyama K; Kitagawa T; Kominami R Jpn J Cancer Res; 2002 Sep; 93(9):994-9. PubMed ID: 12359052 [TBL] [Abstract][Full Text] [Related]
15. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer. Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438 [TBL] [Abstract][Full Text] [Related]
16. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
17. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412 [TBL] [Abstract][Full Text] [Related]
18. Putative tumor-suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status. Hong DP; Mori N; Umesako S; Song CW; Park YG; Aizawa S; Okumoto M J Radiat Res; 2002 Jun; 43(2):175-85. PubMed ID: 12238332 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53. Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R Mol Carcinog; 1999 Jan; 24(1):57-63. PubMed ID: 10029411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]